Leptin elimination in hyperleptinaemic peritoneal dialysis patients

被引:29
|
作者
Landt, M
Parvin, CA
Dagogo-Jack, S
Bryant, B
Coyne, DW
机构
[1] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
关键词
D O I
10.1093/ndt/14.3.732
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Elevated plasma concentrations of leptin, a hormone thought to regulate body composition by influencing food intake/metabolic rate, are prevalent in renal failure patients. The mechanism for these increases is not knows, but evidence suggests that simple accumulation due to decreased elimination is insufficient explanation. Methods. We studied the incidence of hyperleptinaemia in 28 end-stage renal disease patients treated with continuous ambulatory peritoneal dialysis (CAPD), compared with body-mass-index-and sex-matched controls. Results were separated by gender because women have higher leptin concentrations than men. Excretion of leptin and other substances in dialysis fluid was also studied. Results. Hyperleptinaemia was prevalent in women CAPD subjects, but not in men. Plasma leptin concentrations correlated strongly with the daily excretion of leptin in dialysis fluid. Clearance of leptin in dialysis fluid was greater in men than women CAPD subjects. Single regression analysis found that fasting insulin, glucose content of dialysis fluid, plasma albumin, C-reactive protein, erythropoietin dose, urinary creatinine clearance and plasma beta(2)-microglobulin were not determinants of plasma leptin concentrations. Stepwise forward multiple regression, examining the dependence of plasma leptin on body mass index, renal creatinine clearance, plasma albumin, daily dialysis fluid glucose load, daily leptin in dialysis fluid, erythropoietin dose and plasma C-reactive protein found only erythropoietin dose as a consistent negative predictor of plasma leptin concentrations. Conclusions. The results suggest that hyperleptinaemia of CAPD was due to predisposing loss of renal elimination capacity combined with increased production due to obesity (more prevalent in women subjects of this study) and potentially female gender.
引用
收藏
页码:732 / 737
页数:6
相关论文
共 50 条
  • [1] Elimination of pyrraline in patients on peritoneal dialysis (PD)
    Mizuiri, S
    Miyata, S
    Nakanishi, T
    Kobayashi, M
    Sakai, K
    Fushimi, T
    Aikawa, A
    Ohara, T
    Hasegawa, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0922 - A0922
  • [2] Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients
    Tsujimoto, Y
    Shoji, T
    Tabata, T
    Morita, A
    Emoto, M
    Nishizawa, Y
    Morii, H
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05) : 832 - 838
  • [3] Leptin and proinflammatory cytokines in patients undergoing peritoneal dialysis
    Hilkens, MGEC
    Netea, MG
    Van der Meer, JWM
    Koolen, MI
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (06) : 525 - 526
  • [4] Peritoneal elimination of homocysteine moieties in continuous ambulatory peritoneal dialysis patients
    Vychytil, A
    Födinger, M
    Papagiannopoulos, M
    Wölfl, G
    Hörl, WH
    Sunder-Plassmann, G
    KIDNEY INTERNATIONAL, 1999, 55 (05) : 2054 - 2061
  • [5] Peritoneal magnesium elimination and its clinical relevance in peritoneal dialysis patients
    Holzmann-Littig, Christopher
    McCallum, Wendy
    Heemann, Uwe
    Renders, Lutz
    Bietenbeck, Andreas
    Steubl, Dominik
    CLINICAL NEPHROLOGY, 2020, 94 (04) : 181 - 186
  • [6] Peritoneal transport of procalcitonin (PCT) and its elimination in peritoneal dialysis (PD) patients
    Opatrna, S.
    Klaboch, J.
    Slajsova, H.
    Holubec, I.
    Sefrna, F.
    Topolcan, O.
    Opatrny, K., Jr.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2006, 29 (06): : 379 - 380
  • [7] Peritoneal clearance of leptin in continuous ambulatory peritoneal dialysis
    Arkouche, W
    Juillard, L
    Delawari, E
    Lasne, Y
    Combarnous, F
    Sibaï-Galland, R
    Traeger, J
    Laville, M
    Fouque, D
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05) : 839 - 844
  • [8] Elimination of p-cresol in peritoneal dialysis patients.
    Bammens, B
    Geypens, B
    De Preter, V
    Kuypers, D
    Maes, B
    Vanrenterghem, Y
    Evenepoel, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 394A - 394A
  • [9] Elimination of iomeprol in patients undergoing continuous ambulatory peritoneal dialysis
    Iwamoto, M
    Hiroshige, K
    Suda, T
    Ohta, T
    Ohtani, A
    Nakashima, Y
    PERITONEAL DIALYSIS INTERNATIONAL, 1999, 19 (04): : 380 - 385
  • [10] Changes of serum leptin levels and the influential factors in peritoneal dialysis patients
    晏焕青
    ChinaMedicalAbstracts(InternalMedicine), 2014, 31 (01) : 48 - 48